Charles Schwab Investment Management Inc Dare Bioscience, Inc. Transaction History

Charles Schwab Investment Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	BUY	$1.42 - $2.0 $43,355 - $61,064	30,532 New	30,532 $51,000
Q2 2021 Aug 16, 2021	SELL	$1.21 - $1.89 $24,348 - $38,032	-20,123 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.31 - $3.0 $26,361 - $60,369	20,123 New	20,123 $35,000

267K

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $270M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.